Hepregen's Grant - III Round

Hepregen raised a round of funding on June 27, 2012. Investors include National Science Foundation.

Hepregen, a spinout of MIT, is developing a platform to reduce the liver toxicity caused by approved drugs. The platform is based on technology developed by Sangeeta Bhatia, an associate professor in …

Articles about Hepregen's Grant - III Round: